About Myriad
Events & Presentations
Corporate Governance
Myriad Milestones
Investor Day Presentations
News
Financial
Corporate
Product
Pipeline
Financial Reporting
GAAP to Non-GAAP Reconciliation
Latest Earnings Release
Earnings Presentation
SEC Filings
Quarterly & Annual Reports
Investor FAQs
Email Alerts Subscription
Contact Us
About Myriad
Events & Presentations
Corporate Governance
Myriad Milestones
Investor Day Presentations
News
Financial
Corporate
Product
Pipeline
Financial Reporting
GAAP to Non-GAAP Reconciliation
Latest Earnings Release
Earnings Presentation
SEC Filings
Quarterly & Annual Reports
Investor FAQs
Email Alerts Subscription
Contact Us
News Releases
Categories:
All Categories
Corporate
Products
Pipeline
Financial
Oct 27, 2021
Myriad Genetics to Release Third Quarter Financial Results on November 2, 2021
Financial
Oct 18, 2021
Myriad Genetics Names Pamela Wong as Chief Legal Officer
Corporate
Oct 11, 2021
Americans’ anxiety impacted by the ongoing pandemic, yet 1 in 5 say they won’t seek treatment according to the GeneSight® Mental Health Monitor nationwide survey
Products
Sep 13, 2021
Myriad Genetics Completes Sale of Myriad Autoimmune’s Vectra Testing Business to LabCorp
Corporate
Sep 08, 2021
Only 8% of people remain hopeful after depression medication fails them, according to GeneSight® Mental Health Monitor nationwide survey
Products
Aug 03, 2021
Myriad Genetics Delivers Strong Revenue and Earnings Growth in June 2021 Quarter, Continues to Execute on Strategic Growth & Transformation Plans
Financial
Aug 02, 2021
Myriad Genetics Expands Access to Genetic Testing with Launch of First Polygenic Breast Cancer Risk Assessment Score Validated for Women of All Ancestries
Pipeline
Jul 28, 2021
Myriad Genetics to Release Second Quarter Financial Results on August 3, 2021
Financial
Jul 28, 2021
New research reveals most Americans can’t identify the symptoms of depression
Products
Jul 21, 2021
Myriad Genetics Supports New ACMG Recommendation Statement on Increasing Access to Carrier Screening for All Ethnicities
Corporate
Jul 01, 2021
Myriad Genetics Completes Sale of Myriad RBM to IQVIA’s Q2 Solutions
Corporate
Jun 16, 2021
Thomas P. Slavin, M.D., Named Chief Medical Officer for Myriad Genetics
Corporate
Jun 04, 2021
Myriad Genetics CEO Paul J. Diaz to Present at Goldman Sachs 2021 Virtual Global Healthcare Conference
Corporate
Jun 01, 2021
Myriad Genetics Completes the Sale of Myriad myPath® Melanoma, LLC, Laboratory to Castle Biosciences
Corporate
May 24, 2021
Myriad Genetics Signs Definitive Agreement to Sell Myriad RBM to Q2 Solutions
Corporate
Previous
Next page